You are here

Lexington Biosciences Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
LNB
CSE Index: 
Currency: 

Lexington Biosciences, Inc. is a development stage medical device company operating within the healthcare industry. Lexington is focused on development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The current focus of the company is to develop and market the HeartSentry endothelial function measurement product.

You are here

Lexington Biosciences Inc. (LNB)

SEDAR Information

Company Info

Address
1055 West Hastings Street
Suite 1900
Vancouver, BC V6E 2E9
Canada
Phone
(800) 320-2640
Email
info@lexingtonbiosciences.com
Listing date
Tuesday, May 9, 2017
Transfer Agent
AST Trust Company (Canada)

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
3,785,340
Reserved for Issuance: 
322,740

Bulletins

23/04/2019

2019-0417 – Consolidation - Lexington Biosciences, Inc. (LNB)

Le 23 avril/April 2019

Lexington Biosciences, Inc., has announced a consolidation of its issued and outstanding share capital on the basis of one (1) post‐ consolidation share for each ten (10) pre‐consolidation common shares. 

As a result, the outstanding shares of the company will be reduced to approximately 3,785,340 .

The shares will begin trading on a consolidated basis and with a new CUSIP number on April 24, 2019.

The name and symbol will not change.

Advertisement

Publicité

Latest CSE News

Upcoming Events

11_28_CanEx_Cannabis_Investment_Summit_Website

CanEx Cannabis Investment Summit

Thursday, November 28, 2019 -
9:00am to 6:00pm
12_08_Arcview_Las_Vegas_Website

Arcview Cannabis Investor Forum in Las Vegas

Sunday, December 8, 2019 (All day) to Tuesday, December 10, 2019 (All day)
12_10_14th_MA_Forum_Montreal_Website

14th M&A Forum Montréal

Tuesday, December 10, 2019 -
7:00am to 7:00pm